A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
ASTRO 2025: Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High-Risk Adenocarcinoma of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback